Patent Assignment
Reel/Frame 046762/0849
Confirmatory License
Recorded: 2018-08-09
Pages: 2
Assignor
THE FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2017-01-11
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Enhanced Generation of Cytotoxic T-Lymphocytes by Il-21 Mediated FOXP3 Suppression
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 9, 2018
From: YEE, CASSIAN; LI, YONGQING
To: THE FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 046608/0983 →
Merger and Change of Name
Sep 27, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061613/0897 →